Does preoperative thrombocytosis predict prognosis in stage II colorectal cancer patients?
This study showed that thrombocytosis is a prognostic factor predicting DFS in stage II colorectal cancer patients.
NA moderated the effects of inflammation on pain tolerance. This finding is consistent with a synergistic model whereby inflammation may lower the threshold for pain reporting in individuals with increased vulnerability for somatic symptom reporting.